CoChat

Icotinib-resistant HCC827 cells produce exosomes with mRNA MET oncogenes and mediate the migration and invasion of NSCLC

Open access
Yu, Yiming, Abudula, Maidinaimu, Li, Chaofen, Chen, Zhongbo, Zhang, Yun, Chen, Yichen · 2019 · Respiratory Research

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Abstract

Background: Icotinib has been widely used in patients with non-small cell lung cancer (NSCLC), and have significantly enhanced the overall survival rate of NSCLC patients. However, acquired drug resistance limits its clinical efficacy. Tumor cell-derived exosomes have been reported to participate in various biological processes, including tumor invasion, metastasis and drug resistance. Materials and methods: In the present study, drug resistance was measured by MTT assay. Exosomes were extracted from the cell supernatant using ultracentrifugation and identified by exosomal marker. HCC827 cells were treated with exosomes derived from icotinib-resistant (IR) HCC827 to observe the invasion and migration of parent cells. The expression of exo-mRNA was analyzed by reverse transcription-quantitative polymerase chain reaction (RT-PCR). In addition, 10 exo-mRNAs detecting from the plasma and bronchoalveolar lavage fluid (BALF) of NSCLC patients with icotinib treatment were used to establish a new drug resistant-warning formula. Results: The oncogene MET into exosomes was identified from icotinib-resistant lung cancer cells, and this was also presented in exosomes in NSCLC patients diagnosed with cancer metastasis after icotinib treatment. The knockdown of MET in exosomes significantly decreased the ability of invasion and migration in HCC827 cells. Conclusion: It was suggested that MET might be specifically package and transferred by exosomes to modify the invasion and migration ability of the surrounding icotinib-sensitive cells.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12931-019-1202-z

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 a The MTT assay of HCC827, HCC827IR1 and HCC827IR2 cells at the indicated concentration for 48 h. b The vimentin and cytokeratin-7 expression in HCC827 and HCC827IR cells were identified by immunofluorescence analysis. c The western blot analysis of EGFR and P-EGRF expression in HCC827, HCC827IR and HCC827 cells treated with IR exosomes. d The expression of AXL, GAS6 and MET correlated to epithelial-mesenchymal transition (EMT) detected by qRT-PCR
Fig. 1 a The MTT assay of HCC827, HCC827IR1 and HCC827IR2 cells at the indicated concentration for 48 h. b The vimentin and cytokeratin-7 expression in HCC827 and HCC827IR cells were identified by immunofluorescence analysis. c The western blot analysis of EGFR and P-EGRF expression in HCC827, HCC827IR and HCC827 cells treated with IR exosomes. d The expression of AXL, GAS6 and MET correlated to epithelial-mesenchymal transition (EMT) detected by qRT-PCRCC BY · PubMed Central
Fig. 2 HCC827IR improved the migration ability of HCC827 cells. HCC827 cells were co-cultured with HCC827IR for 24 or 48 h. a The Transwell assay was performed to analyze the cell migration. The cell number of HCC827/HCC827IR was 29.25 ± 1.51 vs. those of HCC827/HCC827 was 10.61 ± 3.81)(P < 0.0001) (b) The cell migration was analyzed by wound-healing assay. The migration rate of HCC827IR/HCC827 in 24 h was 26.5% ± 1.765%, and the migration rate of HCC827/HCC827 in 24 h was 17.37% ± 2.206%, p = 0.0317. c The cell cycle was analyzed by flow cytometry
Fig. 2 HCC827IR improved the migration ability of HCC827 cells. HCC827 cells were co-cultured with HCC827IR for 24 or 48 h. a The Transwell assay was performed to analyze the cell migration. The cell number of HCC827/HCC827IR was 29.25 ± 1.51 vs. those of HCC827/HCC827 was 10.61 ± 3.81)(P < 0.0001) (b) The cell migration was analyzed by wound-healing assay. The migration rate of HCC827IR/HCC827 in 24 h was 26.5% ± 1.765%, and the migration rate of HCC827/HCC827 in 24 h was 17.37% ± 2.206%, p = 0.0317. c The cell cycle was analyzed by flow cytometryCC BY · PubMed Central
Fig. 3 Characterization of exosomes from HCC827IR cell-derived exosomes. a The size distribution analysis of purified exosomes by DLS. b The transmission electron microscopic image of the HCC827IR cell-derived exosomes. Scale bar, 20 nm. c Exosome-specific markers CD9, CD81 and CD63 were detected using western blot analysis. The exosome-depleted supernatant (EDS) used as the control group. d The internalization of HCC827IR cell-derived exosomes in HCC827 cells. The derived HCC827IR cells
Fig. 3 Characterization of exosomes from HCC827IR cell-derived exosomes. a The size distribution analysis of purified exosomes by DLS. b The transmission electron microscopic image of the HCC827IR cell-derived exosomes. Scale bar, 20 nm. c Exosome-specific markers CD9, CD81 and CD63 were detected using western blot analysis. The exosome-depleted supernatant (EDS) used as the control group. d The internalization of HCC827IR cell-derived exosomes in HCC827 cells. The derived HCC827IR cellsCC BY · PubMed Central
Fig. 4 The role of HCC827IR-derived exosomes on HCC827 cells and MET was specifically expressed in IR exosomes. a MTT assay of HCC827 cells with icotinib treatment at different concentrations for 48 h after treatment with HCC827IR cells and icotinib-resistant exosomes. b The expression of the cell cycle and cell cycle arrest-related mRNA (CDk2, CDk4, CDKN1a and CDKN1B) in HCC827 and HCC827 co-cultured with icotinib-resistant exosomes was assessed by qRT-PCR. c The Transwell assay was performed to determine the invasion and migration ability of HCC827 cells after treatment with EDS, icotinib-resistant exosomes, and icotinib-resistant MET−/− exo. The migration and invasion cell numbers were analyzed by t-test. d The MET expression in HCC827IR exosomes was detected by PCR analysis and gel electrophoresis
Fig. 4 The role of HCC827IR-derived exosomes on HCC827 cells and MET was specifically expressed in IR exosomes. a MTT assay of HCC827 cells with icotinib treatment at different concentrations for 48 h after treatment with HCC827IR cells and icotinib-resistant exosomes. b The expression of the cell cycle and cell cycle arrest-related mRNA (CDk2, CDk4, CDKN1a and CDKN1B) in HCC827 and HCC827 co-cultured with icotinib-resistant exosomes was assessed by qRT-PCR. c The Transwell assay was performed to determine the invasion and migration ability of HCC827 cells after treatment with EDS, icotinib-resistant exosomes, and icotinib-resistant MET−/− exo. The migration and invasion cell numbers were analyzed by t-test. d The MET expression in HCC827IR exosomes was detected by PCR analysis and gel electrophoresisCC BY · PubMed Central
Fig. 5 The effect of MET siRNA on HCC827 cells. a The qRT-PCR was performed to investigate the expression of ICAM1, ITGB1, CDC42, GAS6 and MET in HCC827 cells treated with HCC827IR exosomes and MET−/− icotinib-resistant exosomes. b The expression of alpha-actinin 4 was analyzed by western blot, and correspondent t-test was performed
Fig. 5 The effect of MET siRNA on HCC827 cells. a The qRT-PCR was performed to investigate the expression of ICAM1, ITGB1, CDC42, GAS6 and MET in HCC827 cells treated with HCC827IR exosomes and MET−/− icotinib-resistant exosomes. b The expression of alpha-actinin 4 was analyzed by western blot, and correspondent t-test was performedCC BY · PubMed Central
Fig. 6 The role of HCC827IR cell-derived exosomes on lung epithelial cells (BEAS-2B). a The change in BEAS-2B morphology after co-culture with HCC827, HCC827IR and icotinib-resistant exosomes were observed using an optical microscope (at 40× and 100×, respectively). b The comparison of the expression of EGFR and P-EGFR in differently treated BESA-2B cells (including those co-cultured with HCC827, HCC827IR and icotinib-resistant exosomes)
Fig. 6 The role of HCC827IR cell-derived exosomes on lung epithelial cells (BEAS-2B). a The change in BEAS-2B morphology after co-culture with HCC827, HCC827IR and icotinib-resistant exosomes were observed using an optical microscope (at 40× and 100×, respectively). b The comparison of the expression of EGFR and P-EGFR in differently treated BESA-2B cells (including those co-cultured with HCC827, HCC827IR and icotinib-resistant exosomes)CC BY · PubMed Central
Fig. 7 a Compared with the exosome mRNA obtained from BALF with that from plasma, it was found that almost all mRNAs were equally expressed in two types of body fluids, including MET. b In comparing icotinib effectivity in a patient’s plasma exo-mRNA with icotinib-resistant patients, it was found that exo-MET was specifically expressed in icotinib-resistant patients. The CT scan revealed the different processes of the disease after icotinib treatment. c The sensitivity and specificity of score of formula through the ROC curve: AUC = 0.98, P = 0,012, Cut-off value 1 = − 0.7526, and cut-off value 2 = − 0.45115. d The formula log102Score 2nd-Score 1st was used to calculate the relationship between the 10 candidates’ exo-mRNAs and the disease progression by PFS. (median of high score was 4, P = 0.0399)
Fig. 7 a Compared with the exosome mRNA obtained from BALF with that from plasma, it was found that almost all mRNAs were equally expressed in two types of body fluids, including MET. b In comparing icotinib effectivity in a patient’s plasma exo-mRNA with icotinib-resistant patients, it was found that exo-MET was specifically expressed in icotinib-resistant patients. The CT scan revealed the different processes of the disease after icotinib treatment. c The sensitivity and specificity of score of formula through the ROC curve: AUC = 0.98, P = 0,012, Cut-off value 1 = − 0.7526, and cut-off value 2 = − 0.45115. d The formula log102Score 2nd-Score 1st was used to calculate the relationship between the 10 candidates’ exo-mRNAs and the disease progression by PFS. (median of high score was 4, P = 0.0399)CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 37 references

Cited by

See all 35

Metadata

Authors
Yu, Y., Abudula, M., Li, C., Chen, Z., Zhang, Y., & Chen, Y.
Affiliations
Ningbo University (CN)
Corresponding author
Chen, Yichen
Venue
Respiratory Research
Published
2019-10-12
Volume
20
Issue
1
Pages
217-217
ISSN
  • 1465-9921 (ISSN-L)
  • 1465-993X
OpenAlex
W2979393922
Cited by
33
References
37
Citations by year
2025: 2 · 2024: 4 · 2023: 7 · 2022: 9 · 2021: 9 · 2020: 2
FWCI
1.66
Type
journal article
Language
en
Open access
Licence
Locations
  • Respiratory Research (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Natural Science Foundation of Ningbo (2017A610161, 2018A610271)
  • Zhejiang Province Public Welfare Technology Application Research Project (LGF19H040003)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Treatments and Mutations
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Keywords
exosomes, MET oncogene, non-small cell lung cancer, HCC827 cells, tumor-derived exosomes, tumor cell migration, tumor invasion, bronchoalveolar lavage fluid
MeSH terms
Antineoplastic Agents, Immunological, Bronchoalveolar Lavage Fluid, Cell Movement, Drug Screening Assays, Antitumor, Humans, Lung Neoplasms, Neoplasm Invasiveness, Oncogenes, Quinazolines, RNA, Messenger, Gene Expression Regulation, Neoplastic, Drug Resistance, Neoplasm, Proto-Oncogene Proteins c-met, Crown Ethers, Cell Line, Tumor, Exosomes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Icotinib-resistant HCC827 cells produce exosomes with mRNA MET oncogenes and mediate the migration and invasion of NSCLC. https://app.cochat.ai/papers/10.1186/s12931-019-1202-z
The paper
Yu, Y., Abudula, M., Li, C., Chen, Z., Zhang, Y., & Chen, Y. (2019). Icotinib-resistant HCC827 cells produce exosomes with mRNA MET oncogenes and mediate the migration and invasion of NSCLC. Respiratory Research. https://doi.org/10.1186/s12931-019-1202-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.